Page 10 - Norgine Annual Report 2017
P. 10



                                2018 is a year of acceleration for Norgine.
                                Norgine will continue to focus on maximising
                                the sales of its existing products and
                                integrate the Merus Labs International                                                                                                             Executive
                                Inc. business while also pursuing new
                                opportunities to diversify its revenue base
                                and to bring transformative products to                                                                                                            Team

                                In 2018, we anticipate to further launch
                                PLENVU  and LYMPHOSEEK  through our
                                infrastructure and we are also anticipating
                                                                                                                                                                   Peter Stein
                                FDA approval of PLENVU .
                                                                                                                                                              Chief Executive Officer

                                                                                                                                                            Christopher Bath                              Peter Martin
                                                                                                                                                               Chief Financial Officer                    Chief Operating Officer

                                                                                                                                                        Kenneth Scrimgeour                                Paul Pay
                                                                                                                                                            Chief Commercial Officer                      Chief Business Development Officer

                                                                                                                                                         Dr Alastair Benbow                               Sheila Hopkins
                                                                                                                                                              Chief Development and                       Chief Legal Officer
                                                                                                                                                                     Medical Officer

                                                                                                                                                                    Tara Barry                            Philippe Caroff
                                                                                                                                                       Chief Human Resources Officer                      Chief Manufacturing Officer

       9                                                                                                                                                                                                                                10
   5   6   7   8   9   10   11   12